NICORETTE QUICKMIST

Originaltext auf Französisch.

In Kanada zugelassenes natürliches Gesundheitsprodukt

Zusammensetzung

Nicht arzneiliche Inhaltsstoffe

Saveur de menthe, acide hydrochlorique, Sucralose, Poloxamer 407, Glycérine, Eau purifiée, Acesulfame Potassium, propylèneglycol, Bicarbonate de sodium, Trometamol, Éthanol, Saveur de menthe verte, Menthol, Saveur de baies

In Kanada empfohlene Dosen

In Kanada zugelassene Verwendungen

NICORETTE® QuickMist® is an instant release mouth spray that gets to work on cravings in 30 seconds for fast craving relief. NICORETTE(R) QUICKMIST(R) is a form of Nicotine Replacement Therapy (NRT) that can help double your chances of quitting successfully. This mouth spray format is the first of its kind and exclusive to NICORETTE(R). It is the fastest form of nicotine replacement therapy when you crave a cigarette or require relief when experiencing nicotine withdrawal symptoms. For fast and effective craving relief, nothing beats cravings faster. NICORETTE(R) QUICKMIST(R) provides a lower level of nicotine to your blood than cigarettes and allows you to slowly decrease your body's need for nicotine. It works as a temporary aid to help you quit smoking by reducing nicotine withdrawal symptoms such as irritability, frustration, anxiety, difficulty in concentration and restlessness. Without these powerful urges for the cigarettes you "need", getting rid of the "habit" cigarettes becomes much easier. The good news is that NICORETTE(R) QUICKMIST(R) contains no tar or carbon monoxide, and therefore doesn't present the same medical risks as cigarettes. NICORETTE(R) QUICKMIST(R) relieves the cravings fast making you 148% more likely to quit versus placebo. NICORETTE(R) QUICKMIST(R) relieves the cravings fast making you almost 150% more likely to quit versus placebo. NICORETTE(R) QUICKMIST(R) relieves the cravings fast making you 148% more likely to quit versus willpower alone. NICORETTE(R) QUICKMIST(R) relieves the cravings fast making you almost 150% more likely to quit versus willpower alone. NICORETTE(R) QUICKMIST(R) relieves the cravings fast making you 2.48x more likely to quit versus placebo. NICORETTE(R) QUICKMIST(R) relieves the cravings fast making you almost 2.5x more likely to quit versus placebo. NICORETTE(R) QUICKMIST(R) relieves the cravings fast making you 2.48x more likely to quit versus willpower alone. NICORETTE(R) QUICKMIST(R) relieves the cravings fast making you almost 2.5x more likely to quit versus willpower alone. Combination Nicotine Replacement Therapy - patch + as needed oral mist: Now you can have the combined support of NICODERM patch and NICORETTE as needed oral mist/spray products together, for a successful quit. Tackle cravings: NICODERM (patch) for slow release constant support and NICORETTE as needed oral mist/spray for an extra quick fix/dose when you really need to fight back the cravings / when something triggers intense cravings. It can be used to cut down/reduce smoking before stopping completely.

Originaltext auf Englisch.

Eine in Kanada zugelassene Verwendung ist keine in der Europäischen Union zugelassene gesundheitsbezogene Angabe. Beachten Sie das Register gesundheitsbezogener Angaben.

Warnhinweise in Kanada

Known Adverse Reactions : If you experience symptoms of taking too much nicotine, stop taking the product temporarily. After you start again, if symptoms persist, take a lower dose and/or take it less often.

Originaltext auf Englisch.

Contra-Indications : Do not use NICORETTE(R) QUICKMIST(R) if you are under 18 years of age, are pregnant or breastfeeding, are an occasional or non-smoker or are allergic (hypersensitive) to any of the ingredients in the mouth spray.

Originaltext auf Englisch.

Known Adverse Reactions : Like all medicines, NICORETTE(R) QUICKMIST(R) can cause side effects, although not everybody gets them. It can cause the same side effects as other ways of taking nicotine. The side effects generally depend on the dose you take. Some common side effects include: hiccups, headache, nausea; local effects of the spray such as tingling, burning sensation, inflammation or pain in the mouth, lips or throat or changes in taste perception; dryness of the mouth or throat, or increase amounts of saliva; feelings of indigestion; cough; pain or discomfort in the tummy (abdomen) or chest; vomiting, flatulence or diarrhea; tightness or numbness of the throat; feeling tired. The symptoms of overdose include nausea, vomiting, drooling, abdominal pain, diarrhea, sweating, headache, dizziness, disturbed hearing and vision and marked weakness. At high doses, these symptoms may be followed by low blood pressure, weak and irregular pulse, breathing difficulties, extreme exhaustion, circulatory collapse and general convulsions.

Originaltext auf Englisch.

Cautions and Warnings : WARNING: Nicotine is highly addictive. Ask your doctor before use if you have/had: a heart attack or stroke, chest pain (unstable angina) or resting angina, a heart condition that affects your heart rate or rhythm, high blood pressure that is not being controlled by medicines, a history of epilepsy or seizures, severe liver or kidney disease, diabetes, an overactive thyroid gland, a tumour or the adrenal gland (phaeochromocytoma), stomach ulcer, esophagitis . If you have diabetes you may need to monitor your blood sugar levels more closely than normal when you stop smoking and start using this product. Tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription. This is especially important if you take medicines containing theophylline to treat asthma, clozapine for schizophrenia, ropinirole to treat Parkinson's disease. Discontinue using NICORETTE(R) QUICKMIST(R) and consult your doctor if irregular heartbeat or chest pain occurs or if severe persistent stomach upset (indigestion, heartburn) develops. Keep out of reach of children and pets.

Originaltext auf Englisch.

Produktdaten

Andere Namen

Berry, Mint, NICORETTE® QUICKMIST® SmartTrack (TM), Spearmint

Inhaber

Kenvue Canada Inc.

NPN oder DIN-HM

80038858

Status

Aktive Lizenz

Lizenzdatum

18. Januar 2013

Überarbeitungsdatum

16. April 2025

Form

Pulvérisateur oral

Verabreichungsweg

Buccale

Art des Antrags

Officinale

Quelle

Amtlicher Health-Canada-Eintrag, Zulassung 80038858

Licensed Natural Health Products Database (LNHPD), Health Canada: zugelassene Produkte, Inhaltsstoffe, Dosierungen, Verwendungen und Warnhinweise, abgerufen am 27. Oktober 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Originaltext auf Englisch.

Die unter demselben Namen in Europa verkaufte Rezeptur kann abweichen. Diese Angaben ersetzen keinen ärztlichen oder pharmazeutischen Rat.

Liste in der amtlichen Überarbeitung vom 16. April 2025 (Register: Licensed Natural Health Products Database (LNHPD), Health Canada: zugelassene Produkte, Inhaltsstoffe, Dosierungen, Verwendungen und Warnhinweise).

Das Produkt hat sich geändert? Fotografieren Sie die Verpackung.

Ist eine Angabe zu diesem Produkt falsch oder veraltet, ob Sie Leser oder Marke sind? Schreiben Sie an contact@compoatlas.com: Jede Korrektur wird im Korrekturprotokoll veröffentlicht.